SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-040182
Filing Date
2023-11-13
Accepted
2023-11-09 20:24:37
Documents
54
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1474645
2 ex10-2.htm EX-10.2 73878
3 ex10-3.htm EX-10.3 67182
4 ex10-4.htm EX-10.4 67095
5 ex10-5.htm EX-10.5 65983
6 ex10-6.htm EX-10.6 66020
7 ex31-1.htm EX-31.1 17585
8 ex31-2.htm EX-31.2 18111
9 ex32-1.htm EX-32.1 7329
10 ex32-2.htm EX-32.2 7520
  Complete submission text file 0001493152-23-040182.txt   6438380

Data Files

Seq Description Document Type Size
11 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT immx-20230930.xsd EX-101.SCH 38149
12 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT immx-20230930_cal.xml EX-101.CAL 43344
13 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT immx-20230930_def.xml EX-101.DEF 173353
14 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT immx-20230930_lab.xml EX-101.LAB 353264
15 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT immx-20230930_pre.xml EX-101.PRE 259673
48 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 905912
Mailing Address 10573 W. PICO BLVD. #58 LOS ANGELES CA 90064
Business Address 11400 WEST OLYMPIC BLVD. SUITE 200 LOS ANGELES CA 90064 (888) 958-1084
Immix Biopharma, Inc. (Filer) CIK: 0001873835 (see all company filings)

IRS No.: 454869378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41159 | Film No.: 231394323
SIC: 2834 Pharmaceutical Preparations